Cdc2 tyrosine phosphorylation is not required for the S-phase DNA damage checkpoint in fission yeast
dc.contributor.author | Kommajosyula, Naveen | |
dc.contributor.author | Rhind, Nicholas R. | |
dc.date | 2022-08-11T08:08:59.000 | |
dc.date.accessioned | 2022-08-23T16:14:53Z | |
dc.date.available | 2022-08-23T16:14:53Z | |
dc.date.issued | 2006-11-15 | |
dc.date.submitted | 2008-10-15 | |
dc.identifier.citation | <p>Cell Cycle. 2006 Nov 1;5(21):2495-500. Epub 2006 Sep 19.</p> | |
dc.identifier.issn | 1551-4005 (Electronic) | |
dc.identifier.doi | 10.4161/cc.5.21.3423 | |
dc.identifier.pmid | 17102632 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14038/33968 | |
dc.description.abstract | The S-phase DNA damage checkpoint slows replication when damage occurs during S phase. Cdc25, which activates Cdc2 by dephosphorylating tyrosine-15, has been shown to be a downstream target of the checkpoint in metazoans, but its role is not clear in fission yeast. The dephosphorylation of Cdc2 has been assumed not to play a role in S-phase regulation because cells replicate in the absence of Cdc25, demonstrating that tyrosine-15 phosphorylated dc2 is sufficient for S phase. However, it has been reported recently that Cdc25 is involved in the slowing of S phase in response to damage in fission yeast, suggesting a modulatory role for Cdc2 dephosphorylation in S phase. We have investigated the role of Cdc25 and the tyrosine phosphorylation of Cdc2 in the S-phase damage checkpoint, and our results show that Cdc2 phosphorylation is not a target of the checkpoint. The checkpoint was not compromised in a Cdc25 overexpressing strain, a strain carrying nonphosphorylatable form of Cdc2, or in a strain lacking Cdc25. Our results are consistent with a strictly Cdc2-Y15 phosphorylation-independent mechanism of the fission yeast S-phase DNA damage checkpoint. | |
dc.language.iso | en_US | |
dc.relation | <p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17102632&dopt=Abstract">Link to article in PubMed</a></p> | |
dc.relation.url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2562503/ | |
dc.subject | CDC2 Protein Kinase; Cell Cycle; Cell Cycle Proteins; Cell Nucleus; *DNA Damage; Flow Cytometry; *Gene Expression Regulation, Fungal; Genotype; Phosphorylation; *S Phase; Schizosaccharomyces; Time Factors; Tyrosine | |
dc.subject | Life Sciences | |
dc.subject | Medicine and Health Sciences | |
dc.title | Cdc2 tyrosine phosphorylation is not required for the S-phase DNA damage checkpoint in fission yeast | |
dc.type | Journal Article | |
dc.source.journaltitle | Cell cycle (Georgetown, Tex.) | |
dc.source.volume | 5 | |
dc.source.issue | 21 | |
dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/gsbs_sp/620 | |
dc.identifier.contextkey | 651090 | |
html.description.abstract | <p>The S-phase DNA damage checkpoint slows replication when damage occurs during S phase. Cdc25, which activates Cdc2 by dephosphorylating tyrosine-15, has been shown to be a downstream target of the checkpoint in metazoans, but its role is not clear in fission yeast. The dephosphorylation of Cdc2 has been assumed not to play a role in S-phase regulation because cells replicate in the absence of Cdc25, demonstrating that tyrosine-15 phosphorylated dc2 is sufficient for S phase. However, it has been reported recently that Cdc25 is involved in the slowing of S phase in response to damage in fission yeast, suggesting a modulatory role for Cdc2 dephosphorylation in S phase. We have investigated the role of Cdc25 and the tyrosine phosphorylation of Cdc2 in the S-phase damage checkpoint, and our results show that Cdc2 phosphorylation is not a target of the checkpoint. The checkpoint was not compromised in a Cdc25 overexpressing strain, a strain carrying nonphosphorylatable form of Cdc2, or in a strain lacking Cdc25. Our results are consistent with a strictly Cdc2-Y15 phosphorylation-independent mechanism of the fission yeast S-phase DNA damage checkpoint.</p> | |
dc.identifier.submissionpath | gsbs_sp/620 | |
dc.contributor.department | Department of Biochemistry and Molecular Pharmacology | |
dc.contributor.department | Graduate School of Biomedical Sciences | |
dc.source.pages | 2495-500 |